Provided by Tiger Trade Technology Pte. Ltd.

Clene Inc

4.30
-0.0200-0.46%
Volume:8K
Turnover:33.77K
Market Cap:55.25M
PE:-1.23
High:4.40
Open:4.31
Low:4.30
Close:4.32
52wk High:13.50
52wk Low:3.88
Shares:12.85M
Float Shares:9.76M
Volume Ratio:0.93
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5038
EPS(LYR):-2.6548
ROE:-1738.36%
ROA:-56.88%
PB:-2.23
PE(LYR):-1.62

Loading ...

Clene Inc - Prices 1,000,000 Share Underwritten Offering at $7.00 per Share

THOMSON REUTERS
·
May 05

Clene to present at Emerging Growth Conference virtual investor session

Reuters
·
May 05

Clene Price Target Maintained With a $31.00/Share by HC Wainwright & Co.

Dow Jones
·
May 05

Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and Colgate-Palmolive (CL)

TIPRANKS
·
May 04

Clene Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 04

Clene provides update on NDA for ALS following Type C meeting with FDA

TIPRANKS
·
May 04

Clene says FDA open to accelerated approval review for CNM-Au8 ALS NDA

Reuters
·
May 04

BRIEF-After Successful FDA Meeting, Clene Filing Accelerated Approval NDA For Als

Reuters
·
May 04

After Successful FDA Meeting, Clene Filing Accelerated Approval Nda for ALS

THOMSON REUTERS
·
May 04

Clene Inc - FDA Acknowledges Nfl as Potential Surrogate Endpoint for Accelerated Approval

THOMSON REUTERS
·
May 04

Clene Inc - FDA Says Cnm-AU8 Data May Support Nda Under Accelerated Approval Pathway

THOMSON REUTERS
·
May 04

Clene Inc - Nda Submission Supported by Phase 2 Healey ALS and Rescue-ALS Trial Data

THOMSON REUTERS
·
May 04

Clene Inc - to Submit Nda for Cnm-AU8 to FDA in Q3 2026

THOMSON REUTERS
·
May 04

Clene Inc expected to post a loss of 62 cents a share - Earnings Preview

Reuters
·
May 01

Clene 10% owner Chidozie Ugwumba disposes of $118,726 common shares

Reuters
·
May 01

Top Growth Companies With Insider Stakes In April 2026

Simply Wall St.
·
Apr 28

Clene 10% owner Chidozie Ugwumba sells 65,663 shares for $404,603

Reuters
·
Apr 23

Clene 10% owner Chidozie Ugwumba disposes of USD 251,773 common shares

Reuters
·
Apr 18

Clene publishes 2025 annual report, targets FDA accelerated approval path for ALS drug CNM-Au8

Reuters
·
Apr 11

Clene announces annual shareholder meeting

Reuters
·
Apr 11